Bladder clinical trials

Explore recruiting bladder clinical trials.

Recruiting bladder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bladder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled study of daridorexant treatment in adolescents with enuresis: proof-of-concept.

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Phase II Trial assessing Trimodality Therapy With or Without Adjuvant Durvalumab (MEDI4736) to Treat Patients with Muscle-Invasive Bladder Cancer

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of the combination of Cisplatin plus Nab-paclitaxel and Nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive Bladder Cancer. (CA209-6E8, CNN-BC trial)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF EARLY OXYBUTININ TREATMENT FOR BOYS WITH POSTERIOR URETHRAL VALVES - PRETIPUV -

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 clinical study to assess efficacy of Induction ipilimumab/nivolumab to spare the Bladder in urothelial bladder cancer (Indi-Blade)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Bladder trials by city

Bladder in Toronto Bladder in Vancouver Bladder in Montreal Bladder in Calgary Bladder in Edmonton Bladder in Ottawa Bladder in Winnipeg Bladder in Quebec City Bladder in Hamilton Bladder in Kitchener Bladder in London Bladder in Halifax Bladder in New York Bladder in Los Angeles Bladder in Chicago Bladder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease